Results Of A Double-Blind, Randomized, Placebo-Controlled Study Of Nabiximols Oromucosal Spray As Adjunctive Therapy In Advanced Cancer Patients With Chronic Uncontrolled Pain

Pain (Due to Advanced Cancer)

Key Findings

Although not superior to placebo on the primary efficacy endpoint, nabiximols had benefits on multiple secondary endpoints, particularly in US patients. Nabiximols might have utility in patients with advanced cancer who receive a lower opioid dose, such as individuals with early intolerance to opioid therapy.

Information and Links


Link: Results Of A Double-Blind, Randomized, Placebo-Controlled Study Of Nabiximols Oromucosal Spray As Adjunctive Therapy In Advanced Cancer Patients With Chronic Uncontrolled Pain

Year: 2017

DOI: 10.1016/j.jpainsymman.2017.09.001


Ratings

(How Ratings Work)

Pain (Due to Advanced Cancer) — 5


Demonstrable efficacy of cannabis for treatment of Pain (Due to Advanced Cancer) according to the results found in this study.

Drugs Used

Sativex (THC:CBD)